CN101001839A - 制备n-氨基哌啶及其盐的方法 - Google Patents
制备n-氨基哌啶及其盐的方法 Download PDFInfo
- Publication number
- CN101001839A CN101001839A CNA2005800263491A CN200580026349A CN101001839A CN 101001839 A CN101001839 A CN 101001839A CN A2005800263491 A CNA2005800263491 A CN A2005800263491A CN 200580026349 A CN200580026349 A CN 200580026349A CN 101001839 A CN101001839 A CN 101001839A
- Authority
- CN
- China
- Prior art keywords
- formula
- solvent
- compound
- stage
- hal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- LWMPFIOTEAXAGV-UHFFFAOYSA-N piperidin-1-amine Chemical compound NN1CCCCC1 LWMPFIOTEAXAGV-UHFFFAOYSA-N 0.000 title description 12
- 238000000034 method Methods 0.000 title description 9
- 150000003839 salts Chemical class 0.000 title description 5
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 23
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical group CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 12
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 9
- 239000002904 solvent Substances 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 239000000203 mixture Substances 0.000 description 6
- 238000010992 reflux Methods 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 5
- 235000011121 sodium hydroxide Nutrition 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical compound BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 3
- VYSYZMNJHYOXGN-UHFFFAOYSA-N ethyl n-aminocarbamate Chemical compound CCOC(=O)NN VYSYZMNJHYOXGN-UHFFFAOYSA-N 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 229940083608 sodium hydroxide Drugs 0.000 description 3
- YZWKKMVJZFACSU-UHFFFAOYSA-N 1-bromopentane Chemical class CCCCCBr YZWKKMVJZFACSU-UHFFFAOYSA-N 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 125000005843 halogen group Chemical group 0.000 description 2
- UAEPNZWRGJTJPN-UHFFFAOYSA-N methylcyclohexane Chemical compound CC1CCCCC1 UAEPNZWRGJTJPN-UHFFFAOYSA-N 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- QDHHCQZDFGDHMP-UHFFFAOYSA-N Chloramine Chemical class ClN QDHHCQZDFGDHMP-UHFFFAOYSA-N 0.000 description 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- UWSDONTXWQOZFN-UHFFFAOYSA-N N-nitrosopiperidine Chemical compound O=NN1CCCCC1 UWSDONTXWQOZFN-UHFFFAOYSA-N 0.000 description 1
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- QRUDEWIWKLJBPS-UHFFFAOYSA-N benzotriazole Chemical compound C1=CC=C2N[N][N]C2=C1 QRUDEWIWKLJBPS-UHFFFAOYSA-N 0.000 description 1
- 239000012964 benzotriazole Substances 0.000 description 1
- OWIUPIRUAQMTTK-UHFFFAOYSA-N carbazic acid Chemical compound NNC(O)=O OWIUPIRUAQMTTK-UHFFFAOYSA-N 0.000 description 1
- XTEGARKTQYYJKE-UHFFFAOYSA-N chloric acid Chemical compound OCl(=O)=O XTEGARKTQYYJKE-UHFFFAOYSA-N 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 229910000042 hydrogen bromide Inorganic materials 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- GYNNXHKOJHMOHS-UHFFFAOYSA-N methyl-cycloheptane Natural products CC1CCCCCC1 GYNNXHKOJHMOHS-UHFFFAOYSA-N 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- OWIUPIRUAQMTTK-UHFFFAOYSA-M n-aminocarbamate Chemical compound NNC([O-])=O OWIUPIRUAQMTTK-UHFFFAOYSA-M 0.000 description 1
- SXESBRNYONQKLV-UHFFFAOYSA-N n-piperidin-1-ylacetamide Chemical class CC(=O)NN1CCCCC1 SXESBRNYONQKLV-UHFFFAOYSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 150000003053 piperidines Chemical class 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 150000003613 toluenes Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
- C07D295/28—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
- C07D295/28—Nitrogen atoms
- C07D295/30—Nitrogen atoms non-acylated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
- C07D211/98—Nitrogen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
本发明涉及制备下式(I)N-氨基哌啶的新方法。
Description
本发明主题是制备下式N-氨基哌啶的新方法:
在文献中已知许多制备N-氨基哌啶的方法:
-使用哌啶和氯胺的腊希法;
-使用肼和N-乙酰基氨基哌啶的方法;
-使用N-亚硝基哌啶的方法(Lunn,Keefer,J.Org.Chem.,1984,49(19),3470);
-使用戊二醛和苯并三唑的方法(Katritzky A.R.,Wei-Quiang Fan,J.Org.Chem.,1990,55,3205-3209)。
本发明制备N-氨基哌啶(I)及其盐的方法其特征在于:
a)用下式(III)1,5-二卤代戊烷(式中,Hal代表卤素原子):
Hal-(CH2)5-Hal(IH)
处理下式(II)肼基甲酸酯(carbazate)(式中,R代表(C1-C6)烷基、苯基或苄基):
NH2-NH-COOR(II);
b)在酸性介质或碱性介质中处理由此得到的下式哌啶-1-基肼基甲酸酯(其中,R代表(C1-C6)烷基、苯基或苄基):
以制备所需N-氨基哌啶。
如果需要,可以与无机酸或有机酸反应制备N-氨基哌啶(I)的盐。
术语“卤素原子”是指溴、氯或碘原子。
在室温与溶剂回流温度之间,在溶剂中实施阶段a),该溶剂例如乙腈或甲苯。
在室温与溶剂回流温度之间,在酸性介质或碱性介质存在下在溶剂中实施阶段b),该酸性介质例如存在盐酸或氢溴酸,该碱性介质例如存在氢氧化钾或氢氧化钠,该溶剂例如水或乙醇。
根据本发明一个优选具体实施方案,阶段a)中,在乙腈中加热回流溶剂,使用式(III)化合物(式中,Hal代表溴原子)处理式(II)化合物(式中,R代表乙基)。
根据本发明一个优选具体实施方案,阶段b)中,在水中,加热回流溶剂,使用氢氧化钠处理式(IV)化合物(式中,R代表乙基)。
优选,制备N-氨基哌啶的盐,例如氢溴酸盐、氢氯酸盐或草酸盐。例如,可以在溶剂(例如甲基叔丁基醚(MTBE))中制备N-氨基哌啶氢溴酸盐。
实施例
A-哌啶-1-基肼基甲酸乙基酯
制备565.3g的在373ml乙腈中的肼基甲酸乙基酯的混合物。将415.4g 1,5-二溴代戊烷倾倒于上述混合物中,回流。保持回流3小时。真空下通过冷凝除去乙腈。如此得到的残留物溶于甲苯/水混合物中。加入30%NaOH使得该两相混合物pH=5。沉积并使用甲苯再提取分离水相。将水和36%HCl加入到合并的甲苯相中。使用甲基叔-丁基醚(MTBE)洗该“富含”水相3-4次以除去中性物质(杂质、肼基甲酸二乙基酯、残留二溴代戊烷)。在甲苯存在下,使用NaOH然后使用NaHCO3碱化该酸性水相。使用甲苯再提取水相。使用水洗甲苯相,以消耗残留的肼基甲酸乙基酯。浓缩干燥该甲苯相。通过在甲基环己烷中再结晶纯化该产物,得到252g白色粉末形式的所需产物。
1H NMR(300MHz):δ(ppm):1.23:t:3H;4.14:qd:2H;2.70:t:4H;1.66:qt:4H;1.36:qt:2H;5.54:bs:1H。
B-N-氨基哌啶
将160g上述阶段得到的化合物、214ml水和120g氢氧化钠珠的混合物回流3小时,同时使用氩气冲扫。冷却后,再过滤存在的无机物质之前,加入640ml MTBE。得到在MTBE中的粗N-氨基哌啶溶液。
C-制备粗N-氨基哌啶氢溴酸盐
25℃下,于0.5小时内将约1体积36%w/w氢溴酸的乙醇溶液与上述阶段得到的N-氨基哌啶在MTBE中的溶液反应。观察到沉淀的生成,搅拌该混合物1小时。20℃下过滤氢溴酸盐,并使用乙醇然后使用MTBE洗。然后在真空下45-50℃下干燥,得到156g所需化合物。
M.p.=177-177.5℃(文献174-175℃)。
Claims (7)
2.根据权利要求1的方法,其特征在于在阶段a)中,在室温与溶剂回流温度之间在溶剂中实施该反应,其中溶剂选自乙腈或甲苯。
3.根据权利要求1或2的方法,其特征在于在阶段b)中,在室温与溶剂回流温度之间,使用酸或碱在溶剂中实施反应,该酸选自盐酸或氢溴酸,该碱选自氢氧化钾或氢氧化钠,该溶剂例如水或乙醇。
4.根据权利要求1-3任一项的方法,其特征在于阶段a)中,在乙腈中,加热回流溶剂,使用式(III)化合物处理式(II)化合物,式(III)中Hal代表溴原子,式(II)中R代表乙基。
5.根据权利要求1-4任一项的方法,其特征在于阶段b)中,在水中,加热回流溶剂,使用氢氧化钠处理式(IV)化合物,式中R代表乙基。
6.根据权利要求1-5任一项的方法,其特征在于制备式(I)化合物的盐,其选自氢溴酸盐、氢氯酸盐或草酸盐。
7.根据权利要求1-6任一项的方法,其特征在于在甲基叔丁基醚中制备式(I)化合物的氢溴酸盐。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0408700 | 2004-08-05 | ||
FR0408700A FR2874013B1 (fr) | 2004-08-05 | 2004-08-05 | Procede de preparation de la n-aminopiperidine et de ses sels |
Publications (1)
Publication Number | Publication Date |
---|---|
CN101001839A true CN101001839A (zh) | 2007-07-18 |
Family
ID=34947045
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2005800263491A Pending CN101001839A (zh) | 2004-08-05 | 2005-08-02 | 制备n-氨基哌啶及其盐的方法 |
Country Status (16)
Country | Link |
---|---|
US (2) | US20070173648A1 (zh) |
EP (1) | EP1776341A1 (zh) |
JP (1) | JP2008509114A (zh) |
KR (1) | KR20070048765A (zh) |
CN (1) | CN101001839A (zh) |
AR (1) | AR050089A1 (zh) |
AU (1) | AU2005279087A1 (zh) |
BR (1) | BRPI0514076A (zh) |
CA (1) | CA2576718A1 (zh) |
FR (1) | FR2874013B1 (zh) |
IL (1) | IL180870A0 (zh) |
MX (1) | MX2007001140A (zh) |
RU (1) | RU2373196C2 (zh) |
TW (1) | TW200621713A (zh) |
UY (1) | UY29045A1 (zh) |
WO (1) | WO2006024778A1 (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2864081B1 (fr) * | 2003-12-17 | 2006-04-28 | Isochem Sa | Procede de synthese de derives de cycloalkyl-hydrazines exocycliques et de derives d'heterocycloalkyl-hydrazines exocycliques. |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE338609C (de) | 1919-10-15 | 1921-06-22 | Fritz Sommer Dr | Verfahren zur Darstellung von Hydrazin und dessen Alkyl- oder Arylsubstitutionsprodukten |
US3317607A (en) * | 1959-07-30 | 1967-05-02 | Fmc Corp | Chemical reduction of nitrosamines |
DE4138142C2 (de) * | 1991-11-20 | 1996-04-25 | Cassella Ag | Verfahren zur Herstellung von 1-Amino-2,6-dimethylpiperidin |
US5977360A (en) * | 1996-12-27 | 1999-11-02 | Japan Hydrazine Co., Ltd. | Process for producing cyclic hydrazine derivatives, tetra-hydropyridazine and hexahydropyridazine |
JP4118559B2 (ja) * | 2001-12-19 | 2008-07-16 | 日本曹達株式会社 | 脂環式ヒドラジンの製造方法 |
JP2004137181A (ja) * | 2002-10-17 | 2004-05-13 | Nippon Soda Co Ltd | N−アミノピペリジンの製造法 |
JP2004137182A (ja) * | 2002-10-17 | 2004-05-13 | Nippon Soda Co Ltd | N−アミノピペリジンの製造方法 |
-
2004
- 2004-08-05 FR FR0408700A patent/FR2874013B1/fr not_active Expired - Fee Related
-
2005
- 2005-08-02 KR KR1020077005078A patent/KR20070048765A/ko not_active Withdrawn
- 2005-08-02 CN CNA2005800263491A patent/CN101001839A/zh active Pending
- 2005-08-02 AR ARP050103210A patent/AR050089A1/es active IP Right Grant
- 2005-08-02 CA CA002576718A patent/CA2576718A1/fr not_active Abandoned
- 2005-08-02 WO PCT/FR2005/002016 patent/WO2006024778A1/fr active Application Filing
- 2005-08-02 EP EP05796225A patent/EP1776341A1/fr not_active Withdrawn
- 2005-08-02 UY UY29045A patent/UY29045A1/es not_active Application Discontinuation
- 2005-08-02 RU RU2007107806/04A patent/RU2373196C2/ru not_active IP Right Cessation
- 2005-08-02 JP JP2007524372A patent/JP2008509114A/ja active Pending
- 2005-08-02 BR BRPI0514076-5A patent/BRPI0514076A/pt not_active IP Right Cessation
- 2005-08-02 MX MX2007001140A patent/MX2007001140A/es active IP Right Grant
- 2005-08-02 AU AU2005279087A patent/AU2005279087A1/en not_active Abandoned
- 2005-08-04 TW TW094126537A patent/TW200621713A/zh unknown
-
2007
- 2007-01-22 US US11/625,367 patent/US20070173648A1/en not_active Abandoned
- 2007-01-22 IL IL180870A patent/IL180870A0/en unknown
-
2008
- 2008-06-30 US US12/164,379 patent/US7951952B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
IL180870A0 (en) | 2009-02-11 |
JP2008509114A (ja) | 2008-03-27 |
RU2373196C2 (ru) | 2009-11-20 |
UY29045A1 (es) | 2006-03-31 |
WO2006024778A1 (fr) | 2006-03-09 |
FR2874013B1 (fr) | 2006-09-29 |
FR2874013A1 (fr) | 2006-02-10 |
AR050089A1 (es) | 2006-09-27 |
CA2576718A1 (fr) | 2006-03-09 |
TW200621713A (en) | 2006-07-01 |
KR20070048765A (ko) | 2007-05-09 |
RU2007107806A (ru) | 2008-09-10 |
US20070173648A1 (en) | 2007-07-26 |
BRPI0514076A (pt) | 2008-05-27 |
EP1776341A1 (fr) | 2007-04-25 |
US20080306274A1 (en) | 2008-12-11 |
AU2005279087A1 (en) | 2006-03-09 |
US7951952B2 (en) | 2011-05-31 |
MX2007001140A (es) | 2007-04-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2010513494A5 (zh) | ||
RU2652265C2 (ru) | Способ получения вортиоксетина | |
JP2010531876A5 (zh) | ||
JP2016509042A5 (zh) | ||
JP2005501841A5 (zh) | ||
JP2010536713A5 (zh) | ||
CN106632014B (zh) | 一种2-氨基-5-氯吡啶的制备方法 | |
JP7144873B2 (ja) | スガマデクスナトリウム塩の製造方法 | |
JP2001055379A (ja) | 1−メチル−1,2,3,4−テトラヒドロイソキノリンの製造方法 | |
CN101001839A (zh) | 制备n-氨基哌啶及其盐的方法 | |
CN101311169A (zh) | 4-(1-羟基-1-甲基乙基)-2-丙基咪唑-5-羧酸乙酯的制备方法 | |
CN1956963A (zh) | 制备n-哌啶子基-1,5-二苯基吡唑-3-羧酰胺衍生物的方法 | |
JP6228210B2 (ja) | フルボキサミン遊離塩基の精製方法およびそれを用いた高純度フルボキサミンマレイン酸塩の製造方法 | |
CN105189467B (zh) | 制备哒嗪酮化合物的方法 | |
CZ295949B6 (cs) | Způsob výroby fexofenadinu | |
JP7252978B2 (ja) | 2-(1-(tert-ブトキシカルボニル)ピペリジン-4-イル)安息香酸を調製するためのプロセス | |
CA2892919A1 (en) | Process for making reverse transcriptase inhibitors | |
KR102443873B1 (ko) | 피리미딘일 바이피리딘 화합물의 제조방법 및 그를 위한 중간체 | |
JP4707976B2 (ja) | 4,4’−ジカルボキシ−2,2’−ビピリジンの製造方法 | |
CN108264489B (zh) | 一种在水中合成喹唑啉的方法 | |
JP2005520805A5 (zh) | ||
EP1471058B1 (en) | Process for producing 1,2,3-triazole compound | |
JP6802815B2 (ja) | ジクロロキノン誘導体の製造方法 | |
KR100701420B1 (ko) | 비페닐테트라졸 유도체의 제조방법 | |
JP2003517029A (ja) | トリフルオロメチルアセトフェノンの製造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1109398 Country of ref document: HK |
|
AD01 | Patent right deemed abandoned |
Effective date of abandoning: 20070718 |
|
C20 | Patent right or utility model deemed to be abandoned or is abandoned | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1109398 Country of ref document: HK |